Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-500
Closed -$104K 219
2022
Q4
$104K Hold
500
0.01% 202
2022
Q3
$109K Hold
500
0.01% 196
2022
Q2
$105K Sell
500
-605
-55% -$129K 0.01% 205
2022
Q1
$271K Sell
1,105
-356
-24% -$86.1K 0.02% 180
2021
Q4
$384K Hold
1,461
0.03% 149
2021
Q3
$385K Sell
1,461
-4,017
-73% -$1.1M 0.07% 155
2021
Q2
$1.35M Sell
5,478
-140
-2% -$29.4K 0.13% 154
2021
Q1
$1.09M Buy
5,618
+2,183
+64% +$438K 0.11% 171
2020
Q4
$720K Buy
3,435
+1,974
+135% +$394K 0.17% 144
2020
Q3
$250K Buy
1,461
+500
+52% +$92.3K 0.05% 191
2020
Q2
$185K Hold
961
0.03% 188
2020
Q1
$142K Sell
961
-2,278
-70% -$363K 0.03% 174
2019
Q4
$501K Sell
3,239
-6,689
-67% -$964K 0.05% 270
2019
Q3
$1.32M Buy
9,928
+3,473
+54% +$455K 0.07% 302
2019
Q2
$780K Hold
6,455
0.06% 309
2019
Q1
$663K Sell
6,455
-6,138
-49% -$634K 0.05% 332
2018
Q4
$1.4M Buy
12,593
+11,632
+1,210% +$1.25M 0.17% 151
2018
Q3
$110K Sell
961
-13,448
-93% -$1.47M 0.01% 380
2018
Q2
$1.51M Sell
14,409
-14,752
-51% -$1.49M 0.09% 229
2018
Q1
$2.79M Buy
29,161
+22,350
+328% +$2.11M 0.11% 233
2017
Q4
$591K Buy
+6,811
New +$563K 0.02% 432

Other funds holding RMD

Meag Munich Ergo's RMD Position: Q1 2023 in Review

Meag Munich Ergo sold out of ResMed (RMD) in Q1 2023, closing a stake of 500 shares — an estimated $104K sold.

Meag Munich Ergo first reported a position in RMD in Q4 2017 and held it in 21 quarters. The position peaked at $2.79M in Q1 2018. 676 funds tracked by Wall St. Rank hold RMD as of Q1 2023.

  • Meag Munich Ergo reported no remaining ResMed position as of Q1 2023 after selling out during the quarter.
  • Meag Munich Ergo sold 500 ResMed shares in Q1 2023, an estimated $104K.
  • Meag Munich Ergo first reported a position in ResMed in Q4 2017 and held it in 21 quarters.
  • Meag Munich Ergo's ResMed position peaked at $2.79M in Q1 2018.
  • 676 funds tracked by Wall St. Rank held ResMed as of Q1 2023.

Based on Meag Munich Ergo's 13F filing for Q1 2023, filed 20 Apr 2023.